Benign Prostatic Hyperplasia Treatment Report

By www.reliablemarketinsights.com

Report Details

Report Name

Global And United States Benign Prostatic Hyperplasia Treatment Market Report & Forecast 2023-2028 Story

Pages

108

Price

$ 4350

Features

Benign Prostatic Hyperplasia Treatment Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Abbott
Allergan plc
Astellas Pharma
Asahi Kasei Corporation
Boehringer Ingelheim GmbH
GlaxoSmithKline
Pfizer
Sanofi
Teva Pharmaceutical Industries
Merck
Boston Scientific Corporation
Teleflex Incorporated
Endo International
Urologix
LISA Laser
Olympus